Archives of Gynecology and Obstetrics

, Volume 287, Issue 5, pp 865–873 | Cite as

Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?

  • Sanjib Kumar Ghosh
  • Shashi Raheja
  • Anita Tuli
  • Chitra Raghunandan
  • Sneh Agarwal
Maternal-Fetal Medicine

Abstract

Purpose

To determine whether maternal serum placental growth factor (PlGF) is more effective as a biomarker in predicting the occurrence of early onset preeclampsia in first trimester or early second trimester of pregnancy.

Methods

A prospective cohort study was conducted on women with singleton pregnancies, screened from the antenatal clinic. Serum PlGF estimation was done at 11–14 weeks of gestation on 1,244 women and at 22–24 weeks of gestation on 1,206 women from the initial study population. A cut-off value of <228 pg/ml for serum PlGF at 11–14 weeks of gestation and <144 pg/ml for serum PlGF at 22–24 weeks of gestation were determined by receiver operating characteristic (ROC) curve analysis for identifying pregnant women at risk of developing early onset preeclampsia (<32 weeks of gestation). Univariate logistic regression analysis was used to analyze the association between serum PlGF < 228 pg/ml at 11–14 weeks of gestation and <144 pg/ml at 22–24 weeks of gestation with the occurrence of early onset preeclampsia and odds ratio (OR) was computed. P value < 0.05 was considered statistically significant in this study.

Results

Maternal serum PlGF <144 pg/ml at 22–24 weeks of gestation had a stronger association (OR 18.83; 95 % CI 12.08–22.24; p = 0.000) than serum PlGF <228 pg/ml at 11–14 weeks of gestation (OR 2.76; 95 % CI 1.29–3.94; p = 0.007) with the occurrence of early onset preeclampsia. The sensitivity and specificity of serum PlGF <144 pg/ml at 22–24 weeks of gestation (84 and 78, respectively) were much higher than those of serum PlGF <228 pg/ml at 11–14 weeks of gestation (58 and 66, respectively) in predicting early onset preeclampsia.

Conclusion

Maternal serum PlGF may be more effective as a biomarker in early second trimester than in first trimester of pregnancy, in predicting the occurrence of early onset preeclampsia.

Keywords

Placental growth factor Early onset preeclampsia First trimester Early second trimester Logistic regression analysis 

References

  1. 1.
    Pennings JL, Kuc S, Rodenburg W, Koster MP, Schielen PC, de Vries A (2011) Integrative data mining to identify novel candidate serum biomarkers for preeclampsia screening. Prenat Diagn 31(12):1153–1159PubMedGoogle Scholar
  2. 2.
    Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC (2011) Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 66(4):225–239PubMedCrossRefGoogle Scholar
  3. 3.
    Crispi F, Dominguez C, Liurba E, Martin-Gallan P, Cabero L, Gratacos E (2006) Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 195:201–207PubMedCrossRefGoogle Scholar
  4. 4.
    Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E (2008) Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 31:303–309PubMedCrossRefGoogle Scholar
  5. 5.
    Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu K (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672–683PubMedCrossRefGoogle Scholar
  6. 6.
    Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee KY, Goncalves LF (2004) Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstet Gynecol 190:1541–1547PubMedCrossRefGoogle Scholar
  7. 7.
    Andraweera PH, Dekker GA, Roberts CT (2012) The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update 18(4):436–457PubMedCrossRefGoogle Scholar
  8. 8.
    Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH (2010) Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks. Ultrasound Obstet Gynecol 35(6):662–670PubMedGoogle Scholar
  9. 9.
    Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E (2010) Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 203(4): 383.e1-8Google Scholar
  10. 10.
    Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC, Visser GH (2010) First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early onset preeclampsia. BJOG 117(11):1384–1389PubMedCrossRefGoogle Scholar
  11. 11.
    Unal ER, Robinson CJ, Johnson DD, Chang EY (2007) Second-trimester angiogenic factors as biomarkers for future onset preeclampsia. Am J Obstet Gynecol 197(2): 211.e1-4Google Scholar
  12. 12.
    De Vivo A, Baveira G, Giordano D, Todarello G, Corrado F, D’anna R (2008) Endoglin, PlGF and sFlt-1 as markers for predicting preeclampsia. Acta Obstet Gynecol Scand 87(8):837–842PubMedCrossRefGoogle Scholar
  13. 13.
    Diab AE, El-Behery MM, Ebraheim MA, Shehata AE (2008) Angiogenic factors for the prediction of preeclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet 102(2):146–151PubMedCrossRefGoogle Scholar
  14. 14.
    Lambert- Messeriian GM, Palomaki GE, Neveux LM, Chien E, Friedman A (2009) Early onset preeclampsia and second trimester serum markers. Prenat Diagn 29(12):1109–1117CrossRefGoogle Scholar
  15. 15.
    Mishra D, Singh HP (2003) Kuppuswamy’s socioeconomic status scale—a revision. Indian J Pediatr 70(3):273–274PubMedCrossRefGoogle Scholar
  16. 16.
    Davey DA, MacGillivray I (1988) The classification and definition of hypertensive disorders of pregnancy. Am J Obstet Gynecol 158:892–898PubMedGoogle Scholar
  17. 17.
    Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R (2000) Preeclampsia and fetal growth. Obstet Gynecol 96:950–955PubMedCrossRefGoogle Scholar
  18. 18.
    MacKay AP, Berg CJ, Atrash HK (2001) Pregnancy related mortality from preeclampsia and eclampsia. Obstet Gynecol 97:533–538PubMedCrossRefGoogle Scholar
  19. 19.
    Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B (2003) The frequency and severity of placental findings in women with preeclampsia and gestational age dependent. Am J Obstet Gynecol 189:1173–1177PubMedCrossRefGoogle Scholar
  20. 20.
    Sebire NJ, Goldin RD, Regan L (2005) Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol 25:117–118PubMedCrossRefGoogle Scholar
  21. 21.
    Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592–1594PubMedCrossRefGoogle Scholar
  22. 22.
    Rasmussen S, Irgens LM (2003) Fetal growth and body proportion in preeclampsia. Obstet Gynecol 101:575–583PubMedCrossRefGoogle Scholar
  23. 23.
    Aardema MW, Saro MC, Lander M, De Wolf BT, Oosterhof H, Aarnoudse JG (2004) Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities? Clin Sci (Lond) 106:377–382CrossRefGoogle Scholar
  24. 24.
    Smith GC, Wear H (2009) The perinatal implications of angiogenic factors. Curr Opin Obstet Gynecol 21(2):111–116PubMedCrossRefGoogle Scholar
  25. 25.
    Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF (2007) Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 196(4):326.e1–326.e13CrossRefGoogle Scholar
  26. 26.
    Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E (2009) A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 22(11):1021–1038PubMedCrossRefGoogle Scholar
  27. 27.
    Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H (2008) A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble VEGF receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small-for-gestational-age neonate. J Matern Fetal Med 21(1):9–23CrossRefGoogle Scholar
  28. 28.
    Wulff C, Wilson H, Dickson SE, Wiegand SJ, Fraser HM (2002) Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy. Biol Reprod 66:802–812PubMedCrossRefGoogle Scholar
  29. 29.
    Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395PubMedCrossRefGoogle Scholar
  30. 30.
    Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242–248PubMedCrossRefGoogle Scholar
  31. 31.
    Pijnenborg R, Robertson WB, Brosens I, Dixon G (1981) Trophoblast invasion and the establishment of hemochorial placentation in man and laboratory animals. Placenta 2:71–91PubMedCrossRefGoogle Scholar
  32. 32.
    Gerretsen G, Huisjes HJ, Elema JD (1981) Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. BJOG 88:876–881CrossRefGoogle Scholar
  33. 33.
    Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mortl M, Beckmann MW (2007) Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 29:407–413PubMedCrossRefGoogle Scholar
  34. 34.
    Khaliq A, Dun KC, Jiang J, Shams M, Li XF (1999) Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor estimation: molecular evidence for “placental hypoxia’ in intrauterine growth restriction. Lab Invest 79(2):151–170PubMedGoogle Scholar
  35. 35.
    Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y (2004) Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145:4838–4845PubMedCrossRefGoogle Scholar
  36. 36.
    Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS (1997) Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 18:657–665PubMedCrossRefGoogle Scholar
  37. 37.
    Gomez O, Figueras F, Martinez JM, Del Rio M, Palacio M, Eixarch E (2006) Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 28:802–808PubMedCrossRefGoogle Scholar
  38. 38.
    Kurdi W, Fayyad A, Thakur V, Harrington K (2004) Delayed normalization of uterine artery Doppler waveforms is not a benign phenomenon. Eur J Obstet Gynecol Reprod Biol 117:20–23PubMedCrossRefGoogle Scholar
  39. 39.
    Hafner E, Schuchter K, Metzenbauer M, Philipp K (2000) Uterine artery Doppler perfusion in the first and second pregnancies. Ultrasound Obstet Gynecol 16:625–629PubMedCrossRefGoogle Scholar
  40. 40.
    Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS (2001) Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184:1267–1272PubMedCrossRefGoogle Scholar
  41. 41.
    Erez O, Romero R, Espinoza J et al (2008) The change in concentrations of angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent of preeclampsia and SGA. J Matern Fetal Neonatal Med 21(5):279–287PubMedCrossRefGoogle Scholar
  42. 42.
    Chaiworapongsa T, Romero R, Savasan ZA, Kusanovic JP, Ogge G, Soto E (2011) Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med 24(10):1187–1207PubMedCrossRefGoogle Scholar
  43. 43.
    Ness RB, Roberts JM (1996) Heterogenous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175:1365–1370PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Sanjib Kumar Ghosh
    • 1
  • Shashi Raheja
    • 1
  • Anita Tuli
    • 1
  • Chitra Raghunandan
    • 2
  • Sneh Agarwal
    • 1
  1. 1.Department of AnatomyLady Hardinge Medical College and Smt. Sucheta Kriplani HospitalNew DelhiIndia
  2. 2.Department of Obstetrics and GynecologyLady Hardinge Medical College and Smt. Sucheta Kriplani HospitalNew DelhiIndia

Personalised recommendations